| Erika Rosen, LCPC | |
|
23250 Chagrin Blvd Ste 425, Beachwood, OH 44122 | |
| (216) 464-4243 | |
| Not Available |
| Full Name | Erika Rosen |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 23250 Chagrin Blvd Ste 425, Beachwood, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003341637 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 180.010646 (Illinois) | Secondary |
| 101YM0800X | Counselor - Mental Health | E.1800922 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erika Rosen, LCPC 4480 Brainard Rd, Chagrin Falls, OH 44022-1502 Ph: (216) 470-6047 | Erika Rosen, LCPC 23250 Chagrin Blvd Ste 425, Beachwood, OH 44122 Ph: (216) 464-4243 |
News Archive
A new four-year, $20 million grant from the U.S. Centers for Disease Control and Prevention (CDC) will enable Harvard School of Public Health (HSPH) researchers to evaluate the impact and cost-effectiveness of a unique combination of HIV prevention strategies in Botswana.
An article published in Experimental Biology and Medicine identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department of Biotechnology at Korea University in Seoul, reports that inhibition of the actin-binding protein transgelin prevents vasculogenic mimicry (VM), a process that provides tumor cells with the nutrients required for growth.
Polymerase chain reaction could help diagnose Mycoplasmia pneumonia infection in children, researchers say.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that pursuant to the Federal Acquisition Regulations and pending a ruling in a protest recently filed by a competitor the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), has suspended work under the modification the Company announced on February 23, 2010 to its existing contract with BARDA for the research and development of SparVax™. June 11, 2010 is the deadline to rule on the protest.
› Verified 3 days ago
Miss Melissa Nicole Daniele, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 23240 Chagrin Boulevard Suite 270, Beachwood, OH 44122 Phone: 216-765-0500 Fax: 216-765-0521 | |
Lauren Scott Butler, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3401 Enterprise Pkwy, Beachwood, OH 44122 Phone: 866-237-6125 | |
Savannah Galloway, CDCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 23811 Chagrin Blvd Ste 105, Beachwood, OH 44122 Phone: 216-483-1001 | |
Mr. Matthew D Coffman, MA, PCC Counselor Medicare: Medicare Enrolled Practice Location: 25700 Science Park Dr Ste 210, Beachwood, OH 44122 Phone: 216-450-1613 Fax: 216-450-1614 | |
June Carey, CDCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 25201 Chagrin Blvd Ste 390, Beachwood, OH 44122 Phone: 216-910-9015 Fax: 216-910-9015 | |
Latricia Mccray, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2000 Auburn Dr, Beachwood, OH 44122 Phone: 216-502-8369 |